HUP0000240A2 - Farnezil-protein-transzferáz inhibitorként alkalmazható triciklusos vegyületek - Google Patents
Farnezil-protein-transzferáz inhibitorként alkalmazható triciklusos vegyületekInfo
- Publication number
- HUP0000240A2 HUP0000240A2 HU0000240A HUP0000240A HUP0000240A2 HU P0000240 A2 HUP0000240 A2 HU P0000240A2 HU 0000240 A HU0000240 A HU 0000240A HU P0000240 A HUP0000240 A HU P0000240A HU P0000240 A2 HUP0000240 A2 HU P0000240A2
- Authority
- HU
- Hungary
- Prior art keywords
- tricyclic compounds
- inhibition
- compounds useful
- protein transferase
- farnesyl protein
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 102000004357 Transferases Human genes 0.000 title 1
- 108090000992 Transferases Proteins 0.000 title 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 title 1
- 230000005764 inhibitory process Effects 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
A találmány tárgyát (1.0) általános képletű farnezil-protein-transzferáz inhibitor hatású, új, triciklusos vegyületek - aholelőnyösen a nitrogénatom, b, c és d metincsoport; R1, R2, R3 és R4 egymástól függetlenül hidrogén- vagy halogénatom; R5, R6, R7 és R8 hidrogénatom; A és B az 5-ös és 6-os szénatom közötti egyszeres vagy kettős kötéstőlfüggően egy-egy vagy két-két hidrogénatom; X szén- vagy nitrogénatom, vagy CH képletű csoport; és W szubsztituált acilcsoport - és ezeket tartalmazógyógyszerkészítmények, valamint daganatos betegségek kezelésére valóalkalmazásuk képezik. Ó
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71022596A | 1996-09-13 | 1996-09-13 | |
| US87745397A | 1997-06-17 | 1997-06-17 | |
| PCT/US1997/024295 WO1998030558A2 (en) | 1996-09-13 | 1997-09-11 | Tricyclic compounds useful for inhibition of farnesyl protein transferase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0000240A2 true HUP0000240A2 (hu) | 2001-04-28 |
Family
ID=27108399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0000240A HUP0000240A2 (hu) | 1996-09-13 | 1997-09-11 | Farnezil-protein-transzferáz inhibitorként alkalmazható triciklusos vegyületek |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP0942906B1 (hu) |
| JP (1) | JP2002515052A (hu) |
| KR (1) | KR20000068550A (hu) |
| CN (1) | CN1248253A (hu) |
| AT (1) | ATE281450T1 (hu) |
| AU (1) | AU7243298A (hu) |
| BR (1) | BR9712035A (hu) |
| CA (1) | CA2264511C (hu) |
| CZ (1) | CZ84299A3 (hu) |
| DE (1) | DE69731481T2 (hu) |
| ES (1) | ES2232888T3 (hu) |
| HU (1) | HUP0000240A2 (hu) |
| ID (1) | ID22067A (hu) |
| IL (1) | IL128930A0 (hu) |
| NO (1) | NO991231L (hu) |
| NZ (1) | NZ334342A (hu) |
| PL (1) | PL332279A1 (hu) |
| SK (1) | SK33299A3 (hu) |
| TR (1) | TR199901273T2 (hu) |
| WO (1) | WO1998030558A2 (hu) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4826853A (en) * | 1986-10-31 | 1989-05-02 | Schering Corporation | 6,11-Dihydro-11-(N-substituted-4-piperidylidene)-5H-benzo(5,6)cyclohepta(1,2-B)pyridines and compositions and methods of use |
| US5089496A (en) * | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
| KR920014799A (ko) * | 1991-01-18 | 1992-08-25 | 나오가따 다이도 | 신규벤조[5,6]시클로헵타[1,2-b]피리딘 유도체 및 이를 함유하는 항알레르기제 |
| ES2164717T3 (es) * | 1993-10-15 | 2002-03-01 | Schering Corp | Compuestos triciclicos de sulfonamida utiles para inhibir la funcion de la proteina-g y para el tratamiento de enfermedades proliferativas. |
| DK0723538T3 (da) * | 1993-10-15 | 2002-03-18 | Schering Corp | Tricykliske carbamatforbindelser, der er nyttige til inhibition af funktion af G-protein og til behandling af proliferative sygdomme |
| IL111235A (en) * | 1993-10-15 | 2001-03-19 | Schering Plough Corp | Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them |
| US5719148A (en) * | 1993-10-15 | 1998-02-17 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
| US5700806A (en) * | 1995-03-24 | 1997-12-23 | Schering Corporation | Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
| IL117798A (en) * | 1995-04-07 | 2001-11-25 | Schering Plough Corp | Tricyclic compounds useful for inhibiting the function of protein - G and for the treatment of malignant diseases, and pharmaceutical preparations containing them |
| CA2240846C (en) * | 1995-12-22 | 2002-07-16 | Schering Corporation | Tricyclic amides useful for inhibition of g-protein function and for treatment of proliferative diseases |
-
1997
- 1997-09-11 AT AT97955043T patent/ATE281450T1/de not_active IP Right Cessation
- 1997-09-11 IL IL12893097A patent/IL128930A0/xx unknown
- 1997-09-11 ID IDW990089D patent/ID22067A/id unknown
- 1997-09-11 AU AU72432/98A patent/AU7243298A/en not_active Abandoned
- 1997-09-11 DE DE69731481T patent/DE69731481T2/de not_active Expired - Fee Related
- 1997-09-11 NZ NZ334342A patent/NZ334342A/xx unknown
- 1997-09-11 ES ES97955043T patent/ES2232888T3/es not_active Expired - Lifetime
- 1997-09-11 WO PCT/US1997/024295 patent/WO1998030558A2/en active IP Right Grant
- 1997-09-11 CA CA002264511A patent/CA2264511C/en not_active Expired - Fee Related
- 1997-09-11 HU HU0000240A patent/HUP0000240A2/hu unknown
- 1997-09-11 SK SK332-99A patent/SK33299A3/sk unknown
- 1997-09-11 CN CN97199595A patent/CN1248253A/zh active Pending
- 1997-09-11 TR TR1999/01273T patent/TR199901273T2/xx unknown
- 1997-09-11 EP EP97955043A patent/EP0942906B1/en not_active Expired - Lifetime
- 1997-09-11 PL PL97332279A patent/PL332279A1/xx unknown
- 1997-09-11 KR KR1019997002124A patent/KR20000068550A/ko not_active Application Discontinuation
- 1997-09-11 CZ CZ99842A patent/CZ84299A3/cs unknown
- 1997-09-11 BR BR9712035A patent/BR9712035A/pt unknown
- 1997-09-11 JP JP52496198A patent/JP2002515052A/ja not_active Ceased
-
1999
- 1999-03-12 NO NO991231A patent/NO991231L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL128930A0 (en) | 2000-02-17 |
| AU7243298A (en) | 1998-08-03 |
| NZ334342A (en) | 2000-07-28 |
| EP0942906B1 (en) | 2004-11-03 |
| TR199901273T2 (xx) | 1999-09-21 |
| ES2232888T3 (es) | 2005-06-01 |
| SK33299A3 (en) | 2000-06-12 |
| CA2264511A1 (en) | 1998-07-16 |
| BR9712035A (pt) | 1999-08-24 |
| KR20000068550A (ko) | 2000-11-25 |
| DE69731481D1 (de) | 2004-12-09 |
| WO1998030558A2 (en) | 1998-07-16 |
| NO991231L (no) | 1999-05-14 |
| DE69731481T2 (de) | 2005-10-27 |
| EP0942906A2 (en) | 1999-09-22 |
| CZ84299A3 (cs) | 1999-09-15 |
| NO991231D0 (no) | 1999-03-12 |
| CA2264511C (en) | 2003-08-05 |
| PL332279A1 (en) | 1999-08-30 |
| ID22067A (id) | 1999-08-26 |
| CN1248253A (zh) | 2000-03-22 |
| WO1998030558A3 (en) | 1998-10-08 |
| ATE281450T1 (de) | 2004-11-15 |
| JP2002515052A (ja) | 2002-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU95108387A (ru) | Дикетопиперазин, способ его получения, фармацевтическая композиция, применение дикетопиперазина | |
| DE59309786D1 (de) | Enniatine und enniatinderivate zur bekämpfung von endoparasiten | |
| TR199800759T2 (xx) | Protein Kinaz C �nhibit�r�. | |
| TR199800720T2 (xx) | Farnesil transferaz inhibe eden 2-kinolon t�revleri. | |
| MX9800411A (es) | Compuestos quimicos. | |
| MY141457A (en) | 4-mercaptopyrrolidine derivates a farnesyl transferase inhibitors | |
| HUP0001848A2 (hu) | NOS gátló 6-fenil-piridil-2-amin származékok | |
| DK0657458T3 (da) | Inhibitorer af proteinkinase-C | |
| ES2193362T3 (es) | Derivados de 2-pirimidinamina y su procedimiento de preparacion de los mismos. | |
| MX9304360A (es) | Derivados de rapamicina y composiciones farmaceuticas de los mismos. | |
| BR9807674A (pt) | Inibidores bicìclicos da proteìna farnesil transferase | |
| HUP0203575A2 (hu) | Th2 differenciálódás inhibitorokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP0100353A2 (hu) | Urokináz inhibitor hatású naftamidinszármazékok | |
| BR0211305A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto | |
| HUP0000191A2 (hu) | Farnezil-protein-transzferáz inhibitorként alkalmazható új triciklusos piperidinil-vegyületek | |
| ATE282036T1 (de) | Trizyklische antitumor verbindungen mit farnesyl protein transferase inhibierender wirkung | |
| HUP9701193A2 (hu) | N-(4-Aril-tiazol-2-il)-szulfonamid-származékok alkalmazása neurológiai rendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására, új származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
| HUP0203054A2 (hu) | Farnezil protein transzferáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| HUP9901685A2 (hu) | Kolchicinszármazékok és azokat tartalmazó gyógyászati készítmények | |
| ATE380797T1 (de) | Prenyl-transferase inhibitoren | |
| NO991230L (no) | Trisykliske forbindelser for inhibering av G-proteinfunksjon og for behandling av proliferative sykdommer | |
| MX9708452A (es) | Inhibidores de sialidasa bacteriana y metodos para fabricar y usar la misma. | |
| TR199900945T2 (xx) | Matriks metaloproteaz �nleyiciler olarak ikameli 4-bifenil-4-hidroksib�tirik asit t�revleri. | |
| MX9204342A (es) | Indoles. | |
| MD502G2 (ro) | Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin |